Literature DB >> 30023105

Surgery vs. SBRT in retrospective analyses: confounding by operability is the elephant in the room.

William A Stokes1, Chad G Rusthoven1.   

Abstract

Entities:  

Year:  2018        PMID： 30023105      PMCID： PMC6036042          DOI： 10.21037/jtd.2018.05.40

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

1.  Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.

Authors:  Sashendra Senthi; Frank J Lagerwaard; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  Lancet Oncol       Date:  2012-06-22       Impact factor: 41.316

2.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica Bauman; Lucian R Chirieac; Thomas A D'Amico; Malcolm M DeCamp; Thomas J Dilling; Michael Dobelbower; Robert C Doebele; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Ritsuko Komaki; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Leah J Leisch; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

3.  A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.

Authors:  Chi-Fu Jeffrey Yang; Arvind Kumar; Jacob A Klapper; Matthew G Hartwig; Betty C Tong; David H Harpole; Mark F Berry; Thomas A D'Amico
Journal:  Ann Surg       Date:  2019-01       Impact factor: 12.969

4.  The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer?

Authors:  Chad G Rusthoven; David A Palma; Suresh Senan; Brian D Kavanagh
Journal:  J Clin Oncol       Date:  2017-02-21       Impact factor: 44.544

5.  Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer.

Authors:  Chad G Rusthoven; Bernard L Jones; Brian D Kavanagh
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02       Impact factor: 5.209

Review 6.  A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.

Authors:  Patrick Murray; Kevin Franks; Gerard G Hanna
Journal:  Br J Radiol       Date:  2017-02-17       Impact factor: 3.039

7.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

8.  Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.

Authors:  Hanbo Chen; Joanna M Laba; R Gabriel Boldt; Christopher D Goodman; David A Palma; Suresh Senan; Alexander V Louie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-03       Impact factor: 7.038

9.  Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.

Authors:  Jeffrey D Bradley; Issam El Naqa; Robert E Drzymala; Marco Trovo; Griffin Jones; Mary Dee Denning
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-30       Impact factor: 7.038

10.  Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.

Authors:  Yasushi Nagata; Masahiro Hiraoka; Taro Shibata; Hiroshi Onishi; Masaki Kokubo; Katsuyuki Karasawa; Yoshiyuki Shioyama; Rikiya Onimaru; Takuyo Kozuka; Etsuo Kunieda; Tsutomu Saito; Keiichi Nakagawa; Masato Hareyama; Yoshihiro Takai; Kazushige Hayakawa; Norio Mitsuhashi; Satoshi Ishikura
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-11       Impact factor: 7.038
View more
  5 in total

1.  Collaborating to assess the role of stereotactic body radiation therapy in medically operable stage I non-small cell lung cancer.

Authors:  Lorraine D Cornwell; Drew Moghanaki
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  The fundamental problem of confounding by medical operability in retrospective comparisons of surgery versus stereotactic body radiation therapy for early-stage lung cancer.

Authors:  Vivek Verma; Chad G Rusthoven
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

3.  Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer.

Authors:  William A Stokes; Niya Xiong; Yuan Liu; Kristin A Higgins; Sibo Tian; Jeffrey D Bradley; Drew Moghanaki; Chad G Rusthoven
Journal:  Clin Lung Cancer       Date:  2022-01-10       Impact factor: 4.840

Review 4.  Individualized Treatment for Advanced Non-Small Cell Lung Cancer: A Case Report and Literature Review.

Authors:  Qianqian Sun; Weiqing Li; Taorui Liu; Huiqin Guo
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

Review 5.  Quality of Life After Stereotactic Body Radiation therapy Versus Video-Assisted Thoracic Surgery in Early stage Non-small Cell Lung Cancer. Is there Enough Data to Make a Recommendation?

Authors:  O Leaman-Alcibar; C Cigarral; C Déniz; I Romero-Palomar; A Navarro-Martin
Journal:  J Clin Transl Res       Date:  2021-04-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.